Table 3.
Serious AE, n (%) | Venetoclax-azacitidine (n = 24) | Placebo-azacitidine (n = 13) |
---|---|---|
Any | 16 (66.7) | 4 (30.8) |
Febrile neutropenia | 10 (41.7) | 0 |
Neutropenia | 4 (16.7) | 0 |
Leukopenia | 2 (8.3) | 0 |
Pneumonia | 3 (12.5) | 1 (7.7) |
Abbreviation:AE, adverse event.